Search

everythinglearnresearchcommunity

for

Search:↓

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

The study concluded that the most common skin problems in women with PCOS are excess hair, acne, oily skin, hair loss, dark skin patches, and skin tags.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Hirsutism in young girls can have causes other than PCOS, so diagnoses should be reassessed if treatments don't work.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Melatonin may help treat PCOS symptoms in rats.